BioNumerik Pharmaceuticals, Inc. — Form D
BioNumerik Pharmaceuticals, Inc. of SAN ANTONIO, TX, a company, filed a Form D exempt-offering notice with the SEC on 2012-11-08. The offering totals $28.9M, of which $10.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-11-08
- Form: D
- Accession: 0000895131-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $28.9M
- Amount sold: $10.2M
- Remaining: $18.7M
- Minimum investment: $25K
- Investors: 3
- Date of first sale: 2012-10-24
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-186708
Issuer
- Name: BioNumerik Pharmaceuticals, Inc.
- CIK: 0000895131
- Entity type: Corporation
- Jurisdiction: TEXAS
- Address: 8122 DATAPOINT DRIVE, SAN ANTONIO, TX, 78229
- Phone: 210-614-1701
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Steve W Carchedi | Director | San Antonio, TX |
| Frederick H Hausheer | Director | San Antonio, TX |
| Harry R Jacobson | Director | Nashville, TN |
| James R Leininger | Director | San Antonio, TX |
| Homer L Pearce | Director | Indianapolis, IN |
| Dennert O Ware | Director | San Antonio, TX |
| John W Yarbro | Director | San Antonio, TX |
| Stacey R Bain | Executive Officer | San Antonio, TX |
| Frederick H Hausheer | Executive Officer | San Antonio, TX |
| Harry R Kochat | Executive Officer | San Antonio, TX |
| David R Margrave | Executive Officer | San Antonio, TX |
Other filings by this issuer (1)
More